4SC AG (4SC AG) EV-to-EBITDA : -15.08 (As of May. 09, 2024)

View and export this data going back to 2008. Start your Free Trial

What is 4SC AG EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, 4SC AG's enterprise value is $124.29 Mil. 4SC AG's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was $-8.24 Mil. Therefore, 4SC AG's EV-to-EBITDA for today is -15.08.

The historical rank and industry rank for 4SC AG's EV-to-EBITDA or its related term are showing as below:

FSCGF' s EV-to-EBITDA Range Over the Past 10 Years
Min: -16.43 Med: -5.11 Max: -1.93
Current: -8.97

During the past 13 years, the highest EV-to-EBITDA of 4SC AG was -1.93. The lowest was -16.43. And the median was -5.11.

FSCGF's EV-to-EBITDA is ranked worse than
100% of 454 companies
in the Biotechnology industry
Industry Median: 10.055 vs FSCGF: -8.97

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-09), 4SC AG's stock price is $5.30. 4SC AG's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $0.000. Therefore, 4SC AG's PE Ratio for today is N/A.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.

4SC AG EV-to-EBITDA Historical Data

The historical data trend for 4SC AG's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

4SC AG EV-to-EBITDA Chart

4SC AG Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-EBITDA

Get a 7-Day Free Trial

-3.78

-3.73

-5.87

-5.11

-9.33

4SC AG Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EV-to-EBITDA	Get a 7-Day Free Trial															-5.87	-	-5.11	-	-9.33

Competitive Comparison of 4SC AG's EV-to-EBITDA

For the Biotechnology subindustry, 4SC AG's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

4SC AG's EV-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, 4SC AG's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where 4SC AG's EV-to-EBITDA falls into.

4SC AG EV-to-EBITDA Calculation

4SC AG's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA	=	Enterprise Value (Today)	/	EBITDA (TTM)
	=	124.290	/	-8.244
	=	-15.08

4SC AG's current Enterprise Value is $124.29 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. 4SC AG's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was $-8.24 Mil.

4SC AG (GREY:FSCGF) EV-to-EBITDA Explanation

4SC AG's PE Ratio for today is calculated as:

PE Ratio	=	Share Price (Today)	/	Earnings per Share (Diluted) (TTM)
	=	5.30	/	0.000
	=	N/A

4SC AG's share price for today is $5.30.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. 4SC AG's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $0.000.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

4SC AG EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of 4SC AG's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

4SC AG (4SC AG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 4SC AG (GREY:FSCGF) » Definitions » EV-to-EBITDA

Comparable Companies

Traded in Other Exchanges

VSC:Germany

Address

Fraunhoferstraße 22, Planegg-Martinsried, DEU, 82152

Website

https://www.4sc.com

4SC AG is a clinical-stage biopharmaceutical company developing small-molecule drugs that can target key indications in cancer with high unmet medical needs. Its pipeline is protected by a comprehensive portfolio of patents and currently comprises two drug candidates in clinical development resminostat and Domatinostat. It Geographic area of the company is Germany, the EU, and Other countries, and the majority of the revenue comes from Other Countries.